Can a smartphone app cut migraine days? new trial says yes
NCT ID NCT05616741
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a home-based biofeedback app called Cerebri in 279 adults with episodic migraine. Participants used the app daily for 10 minutes, along with sensors to track muscle tension, heart rate, and finger temperature. The goal was to see if this approach could reduce the number of migraine days compared to a wait-list group. The trial is complete and focused on safety and effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cerebri biofeedback device (app with sensors for muscle tension, heart rate, and temperature)
What this could lead to
If it works, this could offer a drug-free, at-home option to reduce migraine days for people with episodic migraine.
What could go wrong
This is a completed trial, but the effect may be modest and not work for everyone. Biofeedback requires daily commitment, and results may not apply to chronic migraine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akershus University Hospital HF
Lørenskog, Akershus, 1478, Norway
-
Haukeland University Hospital HF
Bergen, 5053, Norway
-
St.Olavs Hospital HF
Trondheim, Norway
-
University Hospital of North Norway
Tromsø, Norway